1.5 |
4.6 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.8 |
2.5 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.7 |
2.0 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 |
4.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.6 |
4.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.6 |
5.0 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
0.5 |
3.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
0.5 |
1.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.5 |
1.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 |
1.4 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
0.4 |
2.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 |
6.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
0.4 |
1.5 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 |
1.1 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
0.4 |
2.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) amylase secretion(GO:0036394) |
0.4 |
1.8 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
0.4 |
1.1 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
0.3 |
2.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
0.3 |
2.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.3 |
2.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
0.3 |
0.8 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
0.2 |
3.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
0.2 |
1.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 |
3.0 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 |
1.6 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 |
0.6 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.1 |
2.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
0.1 |
0.4 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 |
0.7 |
GO:0030242 |
pexophagy(GO:0030242) |
0.1 |
0.5 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 |
0.5 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 |
0.7 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
0.1 |
2.8 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
0.1 |
1.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 |
2.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
0.1 |
1.1 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
0.1 |
0.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
0.1 |
0.9 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) ceramide catabolic process(GO:0046514) sphingoid biosynthetic process(GO:0046520) |
0.1 |
0.8 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
0.1 |
0.4 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
0.1 |
0.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 |
0.8 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) positive regulation of vasculogenesis(GO:2001214) |
0.1 |
0.3 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.1 |
0.6 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 |
0.8 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 |
0.9 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 |
1.6 |
GO:0006298 |
mismatch repair(GO:0006298) |
0.1 |
1.7 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 |
0.4 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
0.1 |
0.7 |
GO:0070633 |
transepithelial transport(GO:0070633) |
0.1 |
1.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
0.0 |
0.8 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 |
2.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 |
0.1 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.0 |
0.0 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
0.0 |
1.6 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
0.0 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
0.0 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 |
0.4 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 |
0.9 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
0.0 |
0.3 |
GO:0033147 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 |
0.3 |
GO:0009301 |
snRNA transcription(GO:0009301) |
0.0 |
1.0 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 |
1.0 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
0.0 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
0.0 |
2.4 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
0.0 |
1.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.0 |
0.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 |
0.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
0.0 |
0.1 |
GO:1900116 |
sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 |
3.0 |
GO:0060348 |
bone development(GO:0060348) |
0.0 |
0.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 |
0.5 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 |
0.5 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
0.0 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 |
0.4 |
GO:0090382 |
phagosome maturation(GO:0090382) |
0.0 |
0.2 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
0.0 |
0.7 |
GO:0006400 |
tRNA modification(GO:0006400) |
0.0 |
0.2 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |